Comparative Efficacy of Dys-Fizz Tablet and Hinguvachadi Churna in Managing Udavartini Yonivyapad

Phase 2

Not yet recruiting

• Conditions: Dysmenorrhea, unspecified. Ayurveda Condition: UDAVARTINI,

• Registration Number: CTRI/2025/04/084874
• Lead Sponsor: Dr Divya Shingare

Brief Summary

Dysmenorrhea, or painful menstruation, affects approximately 70.1% of women in India. Understanding this condition is crucial for improving quality of life and daily functioning. While modern medicine offers temporary relief, Ayurveda provides a holistic approach, particularly through the study of Udavartini Yonivyapad, a type of dysmenorrhea linked to imbalanced Vata dosha. Ayurvedic treatments focus on addressing the root cause, such as balancing Vata through dietary changes, lifestyle modifications, and herbal remedies. This study aims to compare the effectiveness of DYS-fizz tablet and Hinguvachadi Churna in managing Udavartini Yonivyapad. The study will involve 80 patients diagnosed with dysmenorrhea, randomly divided into two groups, with each receiving one of the treatments for three months. Outcomes will be assessed using a range of criteria, including pain intensity, working ability, and menstrual symptoms. The research hopes to bridge Ayurvedic and modern treatments, offering more effective, personalized options for dysmenorrhea management.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2025-04-14
• Study Start: 2025-05-21

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

• Diagnosed patients of Udavartini Yonivyapad ( Patients suffering from dysmenorrhea).
• Patients suffering from dysmenorrhea for the past 3 or more consecutive cycles.

Exclusion Criteria

• Age below 18years and above 40 years.
• Patient coming with chief complaints of painful menstruation with regular.
• Females with irregular menstrual cycle.
• Patients having congenital anomalies leading to dysmenorrhea.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
DYS-FIZZ tablet is more effective than hinguvachadi choorna in management of udavartini yonivyapad	BT- 0th Day | DT- 4th Day of 1st and 2nd cycle of Menstruation | AT- 12th Week | Treatment Duration- 1st 6days of expected munstruation date and 2days of menses for 2cycle | Assesment on 4th Day of menses | Final Assesment on 12th week

Secondary Outcome Measures

Name	Time	Method
Hinguvachadi choorna is equal effective as DYS-FIZZ tablet in udavartini yonivyapad	BT- 0th Day

Trial Locations

Locations (1)

Khemdas Hospital; 🇮🇳 Vadodara, GUJARAT, India

Khemdas Hospital

🇮🇳Vadodara, GUJARAT, India

Dr Divya Shingare

Principal investigator

8408075710

shingaredivya9@gmail.com